97
Because T-705 is a nucleoside analog, its antiviral activity may be attributable primarily 98 to its incorporation into viral RNA and a resulting increase in the virus' mutation frequency.
99
Here we examined T-705 toxicity to MDCK and A549 cells, its activity against seasonal and Sigma-Aldrich) (final concentration, 100 μM) was used to measure the inhibition of NA curve and scale at right in Fig. 1 A, B) . The parental viruses (MOI=0.001 PFU/cell) were 162 passaged in parallel in the absence of T-705.
163
In the high-infectious dose approach, confluent monolayers of MDCK cells (48-well Cell-based influenza polymerase inhibition assay. equivalent genome copy number to obtain the standard curve was done using the formula: (Table 1) .
256
As the observed antiviral activity might be attributable to metabolic inhibition of the host viruses not treated with T-705 (mock-treated viruses) were serially passaged in parallel.
279
The titers of the two seasonal influenza viruses were approximately equal in T-705-280 treated and mock-treated cultures during passages 1-5 ( Fig. 1 A, Table 2 ). In contrast, the mean infectious titers of both 344 viruses decreased significantly under T-705 selection (from 6.7 log 10 PFU/ml to undetectable; P< 345 0.0001) during passages 6-24.
346
To distinguish between naturally occurring defective virus particles and T-705 activity as 
405
We then examined whether T-705 treatment biased the mutation profile toward specific 406 nucleotide mutations, as RNA mutagens are reported to do (6, 9, 34). In untreated viruses, the 407 transition mutations (A→G and T→C) were most common (Fig. 5 B) . the natural mutation profile (Fig. 5 B) . to T-705; therefore, drug-resistant variants are unlikely to emerge in vitro.
430
Lethal mutagenesis is a mechanism by which drug treatment increases the viral mutation 431 rate sufficiently to overwhelm the virus population's ability to retain fitness (27). into the viral genome is known to induce hypermutation (9, 29, 42).
439
We used two approaches to assess the anti-influenza mechanism of T-705: serial passage seasonal influenza A viruses showed a >60% decrease in specific infectivity after 23 passages
448
with T-705), suggesting that T-705 cased lethal mutagenesis.
449
The lethal mutagenesis theory emphasizes the role of a class of defective interfering 450 particles, which can also be produced during the natural course of influenza virus infection.
451
Therefore, we substantiated the role of lethal mutagenesis by demonstrating that the interfering 452 activity generated by T-705 treatment was greater than the interfering activity naturally within the coding viral genome cause the production of functionally impaired mutant proteins.
467
We utilized Sanger sequencing for quasispecies substructuring; this method is much less 468 sensitive than ultradeep sequencing, and therefore we cannot completely rule out the selection of would add to the advantages of an antiviral strategy that targets the viral mutation rate rather than 474 viral proteins.
475
We observed an increased number of G to A and C to T mutations, suggesting that T-
476
705RTP base-pairs with either cytosine or uracil. RNA viruses can also undergo an A-to-G/U-to- Hassan Zaraket for helpful discussions, and Sharon Naron for excellent editing the manuscript.
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